PMID: 6970630Jan 1, 1980Paper

The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin

Cancer Chemotherapy and Pharmacology
J F SmythD G Johns

Abstract

2'-deoxycoformycin (2'-dCF; Pentostatin), a stoichiometric inhibitor of mammalian adenosine deaminase (ado deaminase), exhibits immunosuppressive and antilymphocytic activity in animal test systems. A clinical pharmacology/phase I study of 2'-dCF administered as a single agent has been completed (18 patients). Dose levels ranged from 0.1 mg/kg X 1 to 0.25 mg/kg/day X 5; ado deaminase and 2'-dCF were measured spectrophotometrically. Plasma decay curves were bi-exponential (alpha and beta t 1/2 values about 1 and 10 h respectively). Recovery of unchanged 2'-dCF from urine (48 h) was 32%--48% of the administered drug. Major toxic manifestations were lymphocytopenia (all patients) and urate nephropathy (1 patient, with subsequent patients in the series receiving allopurinol, 300 mg/day). Three partial responses were seen in seven patients with acute lymphocytic leukaemia receiving 0.25 mg 2'-dCF/kg/day X 5.

References

May 26, 1977·The New England Journal of Medicine
Jan 1, 1978·Ciba Foundation Symposium·R Hirschhorn
Nov 14, 1979·Biochemical and Biophysical Research Communications·C FriedenR L Miller
Nov 1, 1979·Biochemical Pharmacology·P M Venner, R I Glazer
Jan 1, 1978·Cancer Chemotherapy and Pharmacology·J F SmythD M Young
Mar 1, 1977·Biochemical Pharmacology·R P AgarwalR E Parks
May 1, 1975·British Journal of Cancer·J F Smyth, K R Harrap
Apr 1, 1975·Journal of Pharmacokinetics and Biopharmaceutics·R J LutzD S Zaharko
Feb 1, 1963·The Australian Journal of Experimental Biology and Medical Science·J G HALL
Jan 1, 1965·Comparative Biochemistry and Physiology·T G BRADY, C I O'DONOVAN
Apr 1, 1939·The Biochemical Journal·E J Conway, R Cooke
Jun 1, 1942·The Biochemical Journal·T Brady

❮ Previous
Next ❯

Citations

Jan 1, 1981·Cancer Chemotherapy and Pharmacology·P P MajorD W Kufe
Jan 1, 1983·Cancer Chemotherapy and Pharmacology·P P MajorD W Kufe
Jul 14, 2005·Journal of Cancer Research and Clinical Oncology·Karin HolwegerHans-Peter Lipp
May 1, 1990·Clinica Chimica Acta; International Journal of Clinical Chemistry·K NakashimaM Shimoyama
Nov 8, 1984·The New England Journal of Medicine·A D Jacobs, R P Gale
Apr 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·A S Bagnara, M S Hershfield
Feb 1, 1985·Journal of Clinical Pathology·H G DrexlerJ Minowada
Mar 28, 2006·Future Oncology·Anthony D Ho, Manfred Hensel
Jan 1, 1990·Leukemia & Lymphoma·C Dearden, D Catovsky
Mar 28, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tadeusz RobakPawel Robak
Jun 1, 1985·Journal of the American Academy of Dermatology·C CamisaB Bouroncle
May 21, 2003·Pediatric Transplantation·Jennifer E Schwartz, Andrew M Yeager
Jun 1, 1985·European Journal of Clinical Investigation·M Le Hir, U C Dubach
Jan 1, 1985·Annals of the New York Academy of Sciences·W Plunkett
Jan 1, 1985·Annals of the New York Academy of Sciences·J E Seegmiller
Mar 22, 2006·Seminars in Hematology·Anthony D Ho, Manfred Hensel
Jan 1, 1996·Clinical Oncology : a Journal of the Royal College of Radiologists·S A Johnson
Dec 2, 2004·Expert Opinion on Pharmacotherapy·Meghan HigmanAllen Chen
Sep 25, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Joseph H AntinDaniel Weisdorf
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Javier Bolaños-MeadeGeorgia B Vogelsang
Dec 1, 1996·Hematology and Cell Therapy·W Plunkett, V Gandhi
Oct 1, 1981·Journal of Pharmacokinetics and Biopharmaceutics·F G King, R L Dedrick
Jul 1, 1993·Cancer·I A JaiyesimiE H Estey
Jul 1, 1992·The Annals of Pharmacotherapy·B J KaneM K Roush
Jan 1, 1985·Annals of the New York Academy of Sciences·J F SmythA V Hoffbrand
Sep 1, 1988·European Journal of Haematology·C Dearden, D Catovsky
Apr 15, 1982·Biochemical Pharmacology·C M Smith, J F Henderson
Jul 7, 1988·Biochimica Et Biophysica Acta·C W LeeS M Jarvis
Jan 1, 1983·Leukemia Research·J P van Laarhoven, C H de Bruyn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.